NASDAQ: AVRAnteris Technologies Global Corp Stock
$5.88-0.11 (-1.84%)
Updated Jan 21, 2025
AVR Price
$5.88
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$5.10
52 Week High
$6.10
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
5.78
Operating Cash Flow
N/A
Beta
-0.68
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine AVR's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
D
Value
C
Growth
C
Momentum
C
Sentiment
D
Safety
F
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important AVR news, forecast changes, insider trades & much more!
AVR News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how AVR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
AVR's short-term liabilities ($16.28M) exceed its short-term assets ($15.17M)
Short-term Liabilities Financials
AVR's short-term assets ($15.17M) exceed its long-term liabilities ($1.92M)
Long-term Liabilities Financials
AVR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
There are 30 more AVR due diligence checks available for Premium users.
Valuation
AVR's financial health
Profit margin
Revenue
$769.0k
Net Income
-$21.9M
Profit Margin
-2,842.5%
Assets to liabilities
Assets
$21.1M
Liabilities
$18.2M
Debt to equity
5.78
AVR's short-term liabilities ($16.28M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AVR's short-term assets ($15.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AVR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
AVR vs Medical Stocks
Anteris Technologies Global Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.